Re Richard N
Research Division, Ochsner Clinic Foundation, New Orleans, USA.
J La State Med Soc. 2011 Jan-Feb;163(1):48-54.
Although the technical prowess of American medicine is widely appreciated, considerable concern centers on the delivery and financing of health care, and, in particular, on issues of cost and access. Progress in addressing these concerns has been slow in coming with standard approaches to reform failing to win wide approval. It is here suggested that a series of relatively straightforward regulatory reforms could redirect the medical delivery enterprise and reduce many of the distortions that plague it today. These regulatory reforms center on insurance portability, the elimination of discounting, insurance reform, the provision of provider-specific outcomes data, and technology assessment. These regulatory changes offer the prospect of making the system more rational and efficient, while minimizing rationing and avoiding major institutional change. They also may stimulate additional novel suggestions for reform.
尽管美国医学的技术实力广受赞誉,但人们对医疗保健的提供和融资,尤其是成本和可及性问题极为关注。在解决这些问题方面,采用标准改革方法进展缓慢,未能赢得广泛认可。本文认为,一系列相对直接的监管改革可以重塑医疗服务行业,减少如今困扰该行业的诸多扭曲现象。这些监管改革集中在保险可携带性、消除折扣、保险改革、提供特定医疗服务提供者的疗效数据以及技术评估等方面。这些监管变革有望使系统更加合理高效,同时尽量减少配给并避免重大体制变革。它们还可能激发更多新颖的改革建议。